Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate
CompletedOBSERVATIONAL
Enrollment
157
Participants
Timeline
Start Date
September 30, 2014
Primary Completion Date
May 31, 2018
Study Completion Date
May 31, 2018
Conditions
Multiple Sclerosis
Trial Locations (1)
80045
University of Colorado Hospital, Aurora
All Listed Sponsors
lead
University of Colorado, Denver
OTHER
NCT02307877 - Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate | Biotech Hunter | Biotech Hunter